Subsequently, in vitro enzyme inhibition assays were conducted to assess the inhibitory effects of the identified Monascus strains on PL, α-Glu, α-Amy, and ACE, aiming to investigate their potential biological activities in mitigating risk factors associated with the major cardiovascular diseases: hypertension, hyperglycemia, and hyperlipidemia. Here, ACE is linked to hyperlipidemia.